China Resources Sanjiu Investment Quality Review (000999.SZ)
Data timestamp: 2026-07-24 22:04 UTC
Quality score: 80/100
Valuation position: current price/base fair value (FV) 0.64
Final signal: WATCHLIST
Core Conclusion
China Resources Sanjiu is a WATCHLIST name. The price/base FV of 0.64 is attractive, but the report keeps the signal at WATCHLIST because conservative FV still needs verification and leverage has recently increased.
- Quality: 80/100, excellent, supported by strong revenue growth, FCF generation, and healthcare cash-flow quality.
- Price: current price is CNY24.70 and market value is about CNY41.11 billion. Conservative/base FV is CNY22.38/CNY38.74 per share.
Business Breakdown
Main-business revenue increased from CNY15.54 billion in 2021 to CNY31.60 billion in 2025, a 19.4% CAGR. Segment margin/profit was not disclosed in the structured source. Latest annual FCF was CNY4.24 billion and is the main valuation anchor.
Management outlook was not captured as quantified data; annual reports, results meetings, and IR disclosures should be checked in follow-up.
Quality Gate
The score is 80/100: business model 7/10, moat 13/20, cash flow 20/20, capital return 11/15, balance sheet 8/10, growth quality 10/10, and management/accounting 11.4/15. Five-year average FCF/Net Income was 1.01 and OCF/Net Income was 1.34. Average ROE was 15.7% and ROIC was 13.5%.
Management/accounting is 76/100, converted to 11.4/15. Capital allocation, incentives, related-party disclosure, and accounting evidence remain follow-up items.
Financial Audit
The valuation uses fiscal 2025-2021 in CNY. 2025 revenue/net profit/OCF/capex/FCF were CNY31.60/CNY3.42/CNY5.51/CNY1.27/CNY4.24 billion. FCF/Revenue was 13.4% and FCF/Net Income was 1.24. Five-year FCF was CNY4.24, CNY3.61, CNY3.33, CNY2.05, and CNY1.01 billion.
Latest cash was CNY4.66 billion and debt was CNY6.46 billion, leaving net debt of CNY1.80 billion. This makes the balance-sheet bridge a real signal constraint.
Valuation
CNY 10Y government yield was 1.7% from ChinaBond on 2026-07-24.
| Scenario | Core Assumption | Multiple Basis | Fair Market Value | FV/Share | Price/FV | Weight | Next Check |
|---|---|---|---|---|---|---|---|
| Conservative | Normalized FCF CNY4.24bn with heavier haircut | g 2.0%, 9.2x | CNY37.24bn | CNY22.38 | 1.10 | 30% | FCF durability |
| Base | Five-year FCF and current state continue | g 4.0%, 15.6x | CNY64.47bn | CNY38.74 | 0.64 | 50% | Revenue and ROIC trend |
| Optimistic | Quality rerating without exceeding cap | g 5.0%, 20.0x | CNY83.14bn | CNY49.95 | 0.49 | 20% | Competition and capital allocation |
Balance-sheet adjustment is -CNY1.70 billion: cash CNY4.20 billion, current financial assets CNY0.35 billion, non-current financial assets CNY0.22 billion, and debt minus CNY6.46 billion. Base FV passes the 0.70 watch threshold but not the 2x gate because conservative FV is not yet verified.
Buy And Monitor
Current action is watch. Upgrade needs price/base FV below 0.70, quality score at least 75, stronger mispricing evidence, and confidence that conservative FV is not overstated. Track revenue, FCF/Net Income, ROIC, net debt, dividends, buybacks, and governance.
Risks
FCF quality passes. Balance sheet is under observation because debt exceeds cash. Governance/accounting and shareholder returns also remain observation items. Two reporting periods with FCF/Net Income below 0.60, debt expansion, financial-asset impairment, or dilutive shareholder returns would reduce normalized FCF and signal.
Research only. Not personalized investment advice.
Sources
Current market and financial baseline: public quote and financial data platforms. Annual reports and official disclosure venues or IR should be used for dividends, buybacks, governance, related parties, incentives, and risks. Risk-free rate: ChinaBond, 2026-07-24.